AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

With Chemours Company (NYSE:CC) and Honeywell controlling a patented duopoly on HFO technology, the demand for these refrigerants is expected to rise despite recent market challenges, positioning ...